Feb. 3 at 8:26 PM
$TOVX 2 FDA fasttracks, a tech that works on two totally different cancers, an invite to show your tech, a promising advice to commence phase 3 from EMA, a looming advice phase 3 from FDA comming. Partners for soc very plausible because soc is old and this enhances. This is way undervalued in my opinion.
